Sedaconda (isoflurane)

Sedaconda is indicated for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age.

Sedaconda(R) is today approved in Austria*, Belgium, Croatia, Denmark, France*. Germany, Italy, Netherlands, Norway, Slovenia, Spain, Sweden and United Kingdom.

*In Austria and France, the treatment will be marketed under the brand name Cedaconda.

We cannot provide detailed information about our prescription medicines on this website, in compliance with regulations.